AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23381178 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel preoperative locator
Number of subjects: 220
Study 21692613 — intervention group
Group type: EXPERIMENTAL
Intervention: TPMT genotyping prior to azathioprine treatment
Number of subjects: 333
Study 21692613 — intervention group
Group type: COMPARATOR
Intervention: No TPMT genotyping prior to azathioprine treatment
Number of subjects: 333
Study 21692613 — intervention group
Group type: EXPERIMENTAL
Intervention: TPMT heterozygotes
Number of subjects: 333
Study 21692613 — intervention group
Group type: EXPERIMENTAL
Intervention: TPMT variant homozygosity
Number of subjects: 333
Study 19058489 — intervention group
Group type: EXPERIMENTAL
Intervention: Low calorie diet A
Number of subjects: 96
Study 19058489 — intervention group
Group type: COMPARATOR
Intervention: Low calorie diet B
Number of subjects: 96
Study 16822119 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate 2-session MET intervention
Number of subjects: 97
Study 16822119 — intervention group
Group type: COMPARATOR
Intervention: 3-month delay condition (Control)
Number of subjects: 97
Study 12589448 — intervention group
Group type: EXPERIMENTAL
Intervention: Diluters that are similar in terms of visual complexity
Number of subjects: 0
Study 12589448 — intervention group
Group type: EXPERIMENTAL
Intervention: Single distractors (diluters)
Number of subjects: 0
Study 12589448 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-cued position of the color bar
Number of subjects: 0
Study 10227081 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg dexamethasone
Number of subjects: 16
Study 10227081 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 9772611 — intervention group
Group type: EXPERIMENTAL
Intervention: Shuizhi-Dahuang mixture with low dosage of antipsychotic drugs
Number of subjects: 67
Study 9772611 — intervention group
Group type: COMPARATOR
Intervention: Antipsychotic drugs only (control group)
Number of subjects: 67
Study 1877599 — intervention group
Group type: EXPERIMENTAL
Intervention: Two blood pressure measurements taken 30 seconds apart using a random-zero sphygmomanometer
Number of subjects: 0
Study 1877599 — intervention group
Group type: EXPERIMENTAL
Intervention: Duplicate blood pressure measurements made by different observers
Number of subjects: 0
Study 1877599 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of random-zero sphygmomanometer in restricted blood pressure ranges
Number of subjects: 0
Study 6854157 — intervention group
Group type: EXPERIMENTAL
Intervention: Faculty assessments of student case histories
Number of subjects: 16
Study 6854157 — intervention group
Group type: EXPERIMENTAL
Intervention: Faculty evaluations influenced by a halo effect
Number of subjects: 16
Study 30591577 — intervention group
Group type: EXPERIMENTAL
Intervention: Safe Delivery App (SDA)
Number of subjects: 64
Study 30591577 — intervention group
Group type: COMPARATOR
Intervention: Standard practice (control)
Number of subjects: 64
Study 27814259 — intervention group
Group type: COMPARATOR
Intervention: Standard medical history questionnaire (n = 107)
Number of subjects: 209
Study 27814259 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical history questionnaire with additional item about dietary supplement use (n = 102)
Number of subjects: 209
Study 27814259 — intervention group
Group type: EXPERIMENTAL
Intervention: Age group analysis
Number of subjects: 209
Study 24563270 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphate binder therapy adherence measurement over 2 months
Number of subjects: 135
Study 24563270 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherent patients
Number of subjects: 135
Study 24563270 — intervention group
Group type: EXPERIMENTAL
Intervention: Determinants for adherence
Number of subjects: 135
Study 24563270 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support and quality of life physical score
Number of subjects: 135
Study 21992583 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinyasa yoga (twice-weekly program)
Number of subjects: 55
Study 21992583 — intervention group
Group type: COMPARATOR
Intervention: General health and wellness program (contact control)
Number of subjects: 55
Study 21992583 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinyasa yoga
Number of subjects: 55
Study 19737297 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric strength training (6-week progressive resistance-strengthening programme, 3 times a week)
Number of subjects: 14
Study 19737297 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric strength training
Number of subjects: 14
Study 19737297 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting control)
Number of subjects: 14
Study 18692646 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrocautery and collagen patches (TachoSil)
Number of subjects: 20
Study 15960407 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% nitrous oxide in oxygen along with lignocaine 40 mg mixed in 1% propofol 20 ml (Group NL)
Number of subjects: 90
Study 15960407 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% nitrous oxide in oxygen without lignocaine in propofol (Group N)
Number of subjects: 90
Study 15960407 — intervention group
Group type: COMPARATOR
Intervention: 50% oxygen in air with lignocaine mixed in propofol 40 mg (Group L)
Number of subjects: 90
Study 12912716 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct-to-consumer advertising (DTCA) patient scenario
Number of subjects: 1784
Study 12912716 — intervention group
Group type: COMPARATOR
Intervention: Drug reference book patient scenario
Number of subjects: 1784
Study 9527556 — intervention group
Group type: EXPERIMENTAL
Intervention: PLA barrier
Number of subjects: 30
Study 9527556 — intervention group
Group type: COMPARATOR
Intervention: ePTFE barrier
Number of subjects: 30
Study 7574752 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal cisplatin (CDDP) chemotherapy, 100 mg of CDDP and 300 ml of saline administered intraperitoneally just after operation for curatively resected patients; same doses for patients with ascites after removal of fluid.
Number of subjects: 12
Study 7574752 — intervention group
Group type: COMPARATOR
Intervention: Intraperitoneal cisplatin (CDDP) chemotherapy for patients with ascites.
Number of subjects: 12
Study 2132185 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow release formulation of bezafibrate (Bezalip Mono)
Number of subjects: 24
Study 2132185 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 340327 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (1200 mg daily)
Number of subjects: 94
Study 340327 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (800 mg daily)
Number of subjects: 94
Study 340327 — intervention group
Group type: COMPARATOR
Intervention: Intensive regimen of Al‐Mg antacid (210 ml daily)
Number of subjects: 94
Study 340327 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (both dosages)
Number of subjects: 94
Study 340327 — intervention group
Group type: COMPARATOR
Intervention: Intensive regimen of Al‐Mg antacid
Number of subjects: 94
Study 340327 — intervention group
Group type: COMPARATOR
Intervention: Antacid treatment
Number of subjects: 94
Study 30427698 — intervention group
Group type: EXPERIMENTAL
Intervention: Six 1-g NaCl tablets (salt intervention trial)
Number of subjects: 14
Study 30427698 — intervention group
Group type: COMPARATOR
Intervention: Placebo trial (six flour tablets)
Number of subjects: 14
Study 30427698 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill walking post sodium ingestion
Number of subjects: 14
Study 30427698 — intervention group
Group type: EXPERIMENTAL
Intervention: DXA scan quantification
Number of subjects: 14
Study 30427698 — intervention group
Group type: EXPERIMENTAL
Intervention: Total body BMC after sodium ingestion
Number of subjects: 14
Study 27854539 — intervention group
Group type: EXPERIMENTAL
Intervention: CHW-led health literacy intervention with tailored cancer-screening brochure, training, and monthly counseling.
Number of subjects: 560
Study 25536489 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical vibration (VV)
Number of subjects: 12
Study 25536489 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 12
Study 25536489 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotational vibration (RV)
Number of subjects: 12
Study 23652897 — intervention group
Group type: EXPERIMENTAL
Intervention: SGP‐HA filler (Restylane®)
Number of subjects: 20
Study 21078916 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression-reducing program (8 sessions, 1 hour each)
Number of subjects: 58
Study 21078916 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 58
Study 19015933 — intervention group
Group type: EXPERIMENTAL
Intervention: PerFix Plug (P)
Number of subjects: 472
Study 19015933 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolene Hernia System (PHS)
Number of subjects: 472
Study 19015933 — intervention group
Group type: COMPARATOR
Intervention: Lichtenstein mesh (L)
Number of subjects: 472
Study 19015933 — intervention group
Group type: EXPERIMENTAL
Intervention: All techniques
Number of subjects: 472
Study 17546380 — intervention group
Group type: EXPERIMENTAL
Intervention: Odontogain ultrasonic scaler (group A)
Number of subjects: 20
Study 17546380 — intervention group
Group type: COMPARATOR
Intervention: Prophy Max ultrasonic scaler (group B)
Number of subjects: 20
Study 15101004 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuirass application and biphasic extra-thoracic ventilation
Number of subjects: 10
Study 15101004 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal (ET) intubation and manual ventilation
Number of subjects: 10
Study 11515277 — intervention group
Group type: EXPERIMENTAL
Intervention: O + S active (Onset 12/89%, Stability 30 ms)
Number of subjects: 103
Study 11515277 — intervention group
Group type: COMPARATOR
Intervention: O + S inactive
Number of subjects: 103
Study 11515277 — intervention group
Group type: EXPERIMENTAL
Intervention: EGW passive with O + S inactive
Number of subjects: 103
Study 11515277 — intervention group
Group type: EXPERIMENTAL
Intervention: EGW passive with O + S active
Number of subjects: 103
Study 11515277 — intervention group
Group type: EXPERIMENTAL
Intervention: O + S active
Number of subjects: 103
Study 9649996 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural analgesia with morphine-bupivacaine combination (Group A)
Number of subjects: 44
Study 9649996 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline) (Group B)
Number of subjects: 44
Study 8530314 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral amoxicillin plus clavulanic acid
Number of subjects: 130
Study 8530314 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sulfamethoxazol and trimethoprim
Number of subjects: 130
Study 8530314 — intervention group
Group type: COMPARATOR
Intervention: No perioperative antibiotics
Number of subjects: 130
Study 2151141 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast self-examination (BSE) practice
Number of subjects: 1315
Study 2151141 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal BSE practice
Number of subjects: 1315
Study 2151141 — intervention group
Group type: COMPARATOR
Intervention: Radical surgery
Number of subjects: 1315
Study 470745 — intervention group
Group type: EXPERIMENTAL
Intervention: Kylie sheet
Number of subjects: 19
Study 470745 — intervention group
Group type: COMPARATOR
Intervention: Cotton drawsheets
Number of subjects: 19
Study 31056885 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive moxibustion plus acupuncture
Number of subjects: 60
Study 31056885 — intervention group
Group type: COMPARATOR
Intervention: Simple acupuncture
Number of subjects: 60
Study 28121183 — intervention group
Group type: EXPERIMENTAL
Intervention: BRC (betalain-rich concentrate)
Number of subjects: 22
Study 24823464 — intervention group
Group type: EXPERIMENTAL
Intervention: Dutasteride (0.5 mg daily; n = 16)
Number of subjects: 46
Study 24823464 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride (5 mg daily; n = 16)
Number of subjects: 46
Study 24823464 — intervention group
Group type: COMPARATOR
Intervention: Tamsulosin (0.4 mg daily; n = 14)
Number of subjects: 46
Study 23093401 — intervention group
Group type: EXPERIMENTAL
Intervention: Active drink (pomegranate extract) consumed during high-fat meal (ET-DUR)
Number of subjects: 19
Study 23093401 — intervention group
Group type: EXPERIMENTAL
Intervention: Active drink (pomegranate extract) consumed 15 min before high-fat meal (ET-PRE)
Number of subjects: 19
Study 23093401 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo drink with no pomegranate extract) consumed during high-fat meal (CONTROL)
Number of subjects: 19
Study 23093401 — intervention group
Group type: EXPERIMENTAL
Intervention: ET-PRE and ET-DUR
Number of subjects: 19
Study 20145447 — intervention group
Group type: EXPERIMENTAL
Intervention: Reiki intervention
Number of subjects: 21
Study 20145447 — intervention group
Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 21
Study 18634163 — intervention group
Group type: EXPERIMENTAL
Intervention: Anakinra 100 mg once daily for up to 36 weeks
Number of subjects: 1207
Study 15857162 — intervention group
Group type: EXPERIMENTAL
Intervention: Very Low Calorie Diet (VLCD) with n-3 Polyunsaturated Fatty Acids (PUFA)
Number of subjects: 20
Study 15857162 — intervention group
Group type: COMPARATOR
Intervention: Very Low Calorie Diet (VLCD) with placebo
Number of subjects: 20
Study 12816624 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress-reduction intervention (16-hour program)
Number of subjects: 38
Study 12816624 — intervention group
Group type: COMPARATOR
Intervention: Waiting control group (no intervention)
Number of subjects: 38
Study 11108570 — intervention group
Group type: EXPERIMENTAL
Intervention: Transurethral microwave thermotherapy (TUMT)
Number of subjects: 0
Study 11108570 — intervention group
Group type: COMPARATOR
Intervention: Alpha-blocker treatment
Number of subjects: 0
Study 11108570 — intervention group
Group type: COMPARATOR
Intervention: Finasteride
Number of subjects: 0
Study 11108570 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant and adjuvant alpha-blocker therapy
Number of subjects: 0
Study 7542928 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational brochures about melanoma (2 brochures)
Number of subjects: 314
Study 7542928 — intervention group
Group type: COMPARATOR
Intervention: Control group 1 (no educational material)
Number of subjects: 314
Study 7542928 — intervention group
Group type: COMPARATOR
Intervention: Control group 2 (questionnaire and chart, no educational material)
Number of subjects: 314
Study 2291755 — intervention group
Group type: EXPERIMENTAL
Intervention: Pivmecillinam 200 mg t.i.d. for 3 days
Number of subjects: 299
Study 2291755 — intervention group
Group type: EXPERIMENTAL
Intervention: Pivmecillinam 200 mg t.i.d. for 7 days
Number of subjects: 299
Study 7304902 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 5 mg
Number of subjects: 41
Study 7304902 — intervention group
Group type: COMPARATOR
Intervention: Diazepam 15 mg
Number of subjects: 41
Study 31154681 — intervention group
Group type: EXPERIMENTAL
Intervention: No rehydration (NR)
Number of subjects: 9
Study 31154681 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-immersion rehydration (RH) with 1 L of water
Number of subjects: 9
Study 31154681 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 9
Study 28391147 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor training programme (daily perineal massage and pelvic floor exercises from 32 weeks of pregnancy until birth)
Number of subjects: 466
Study 28391147 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor training programme
Number of subjects: 466
Study 28391147 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 466
Study 26371518 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin + hydroxychloroquine 200 mg
Number of subjects: 328
Study 26371518 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin 10 mg
Number of subjects: 328
Study 23577913 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based training on cognitive behavioral therapy (CBT) skills
Number of subjects: 127
Study 23577913 — intervention group
Group type: COMPARATOR
Intervention: Written CBT manual (Control)
Number of subjects: 127
Study 21443446 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (n=5)
Number of subjects: 10
Study 21443446 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment, n=5)
Number of subjects: 10
Study 19650515 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilot randomized controlled trial (RCT) intervention
Number of subjects: 0
Study 17194950 — intervention group
Group type: EXPERIMENTAL
Intervention: Music
Number of subjects: 170
Study 17194950 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery
Number of subjects: 170
Study 17194950 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 170
Study 15081180 — intervention group
Group type: EXPERIMENTAL
Intervention: Staged training
Number of subjects: 495
Study 15081180 — intervention group
Group type: COMPARATOR
Intervention: Conventional training
Number of subjects: 495
Study 11495672 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgo biloba (two 60‐mg tablets of BioGinkgo daily for 5 days)
Number of subjects: 30
Study 11495672 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 9754980 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimesulide 100 mg twice daily for 7 days
Number of subjects: 20
Study 9754980 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 8141105 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron 1 mg three times per day for 3 days
Number of subjects: 324
Study 8141105 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron 4 mg three times per day for 3 days
Number of subjects: 324
Study 8141105 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron 8 mg three times per day for 3 days
Number of subjects: 324
Study 8141105 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 324
Study 8141105 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron (all doses)
Number of subjects: 324
Study 8141105 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron 1 mg
Number of subjects: 324
Study 8141105 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron 4 mg
Number of subjects: 324
Study 8141105 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron 8 mg
Number of subjects: 324
Study 3257872 — intervention group
Group type: EXPERIMENTAL
Intervention: D‐penicillamine
Number of subjects: 162
Study 3257872 — intervention group
Group type: EXPERIMENTAL
Intervention: hydroxychloroquine
Number of subjects: 162
Study 3257872 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 162
Study 29618331 — intervention group
Group type: EXPERIMENTAL
Intervention: Alerta Alcohol intervention (EC)
Number of subjects: 16
Study 29618331 — intervention group
Group type: COMPARATOR
Intervention: Control condition (CC)
Number of subjects: 16
Study 27027891 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill training (12 sessions of 45 minutes each, one session a day, three days a week for four weeks)
Number of subjects: 17
Study 27027891 — intervention group
Group type: COMPARATOR
Intervention: Control group (no physical training, regular social interactions following a specific lifestyle program)
Number of subjects: 17
Study 23810271 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% lidocaine emulsion formulation (NOPAYNE™)
Number of subjects: 29
Study 23810271 — intervention group
Group type: COMPARATOR
Intervention: 4% aqueous solution (Xylocaine™)
Number of subjects: 29
Study 23810271 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 29
Study 23774308 — intervention group
Group type: EXPERIMENTAL
Intervention: Submucosal administration of 300 U onabotulinumtoxinA (onaBoNT/A)
Number of subjects: 23
Study 23774308 — intervention group
Group type: COMPARATOR
Intervention: Detrusor administration of 300 U onabotulinumtoxinA (onaBoNT/A)
Number of subjects: 23
Study 23774308 — intervention group
Group type: COMPARATOR
Intervention: Comparison of submucosal vs detrusor administration
Number of subjects: 23
Study 21968660 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin Health Experimental Product (SHEP)
Number of subjects: 0
Study 21968660 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 19242624 — intervention group
Group type: EXPERIMENTAL
Intervention: McKenzie method
Number of subjects: 134
Study 19242624 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthopaedic manual therapy
Number of subjects: 134
Study 19242624 — intervention group
Group type: COMPARATOR
Intervention: Advice-only
Number of subjects: 134
Study 16983840 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. dexamethasone 0.5 mg/kg
Number of subjects: 230
Study 16983840 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 230
Study 14523485 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C and E (600 mg/day each)
Number of subjects: 37
Study 14523485 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 10935153 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrient bar (2 bars/day)
Number of subjects: 43
Study 10935153 — intervention group
Group type: COMPARATOR
Intervention: Placebo bar
Number of subjects: 43
Study 9411419 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroid carcinoma patients
Number of subjects: 71
Study 9411419 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-toxic nodular goitre patients
Number of subjects: 71
Study 9411419 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with autoantibodies (ATG and/or MAB)
Number of subjects: 71
Study 9411419 — intervention group
Group type: COMPARATOR
Intervention: Control group (30 healthy women)
Number of subjects: 71
Study 9411419 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with anti thyroglobulin antibodies (ATG)
Number of subjects: 71
Study 9411419 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with anti thyroid microsomal antibodies (MAB)
Number of subjects: 71
Study 1283698 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg
Number of subjects: 0
Study 1283698 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine 10 mg
Number of subjects: 0
Study 1283698 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 0
Study 3887977 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg ranitidine
Number of subjects: 120